Risk Factors for Complications After Carotid Endarterectomy

Sponsor
Ohio State University (Other)
Overall Status
Terminated
CT.gov ID
NCT03788980
Collaborator
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (Other)
10
2
14.9
5
0.3

Study Details

Study Description

Brief Summary

This study may determine the incidence of complications that occur after patients undergo a surgery called Carotid Endarterectomy (CEA), which is a surgery that aims to decrease the risk of strokes in patients with a condition called carotid stenosis. Medical records will be accessed to find any information pertaining to postoperative complications. Additionally, it may determine the cognitive dysfunction of patients undergoing CEA, assessed by Mini Mental Status Examination (MMSE).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Carotid endarterectomy
  • Diagnostic Test: Mini Mental Status Examination

Detailed Description

This is a multicenter prospective observational study; data will be collected from two sites:

the lead site in Columbus, Ohio, USA and an international site in Girona, Spain for a total of 354 patients. The objective of this study is to determine the incidence of complications that occur after patients undergo a surgery called Carotid Endarterectomy (CEA), which is a surgery that aims to decrease the risk of strokes in patients with a condition called carotid stenosis. Patients who undergo CEA are at increased risk of cardiovascular complications because of the high incidence of coexisting heart disease, high blood pressure, and diabetes. Common complications that occur after CEA are wound hematoma (collection of blood at the wound) and intracerebral hemorrhage (bleeding in the brain). Medical records will be accessed to find any information pertaining to postoperative complications. Another objective of this study is to determine the cognitive dysfunction of patients undergoing CEA. This will be measured by a Mini Mental Status Examination (MMSE) which will occur in person before the surgery and 30 days after the surgery over the phone. This study may provide data that will help identify how to optimize recovery for future CEA patients.

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Risk Factors for Complications After Carotid Endarterectomy: A Multicenter International Observational Study
Actual Study Start Date :
Apr 13, 2018
Actual Primary Completion Date :
Jul 9, 2019
Actual Study Completion Date :
Jul 9, 2019

Arms and Interventions

Arm Intervention/Treatment
carotid endarterectomy group

patients undergoing carotid endarterectomy

Procedure: Carotid endarterectomy
Patients will undergo a surgery called carotid endarterectomy where a surgeon will remove material that causes carotid stenosis (i.e. plaque)
Other Names:
  • CAE
  • Diagnostic Test: Mini Mental Status Examination
    Short questionnaire used to diagnose cognitive dysfunction
    Other Names:
  • MMSE
  • Outcome Measures

    Primary Outcome Measures

    1. Complication rate [30 days]

      Incidence of postoperative complications and identify the associated risk factors.

    Secondary Outcome Measures

    1. Cognitive Dysfunction [30 days]

      the incidence of cognitive dysfunction based on Mini Mental Status Examination

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients males or females, 18 years of age and older

    • Scheduled to undergo Carotid Endarterectomy

    Exclusion Criteria:
    1. Pregnant women

    2. Incarcerated individuals

    3. Patients not able to consent for themselves

    4. Any disease or condition deemed by the investigator to disqualify the patient

    5. Participating in any interventional clinical trial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Ohio State University Wexner Medical Center Columbus Ohio United States 43210
    2 Hospital Universitari de Girona Dr. Josep Trueta Girona Catalonia Spain 17007

    Sponsors and Collaborators

    • Ohio State University
    • Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

    Investigators

    • Principal Investigator: Sergio Bergese, MD, The Ohio State University Wexner Medical Center Department of Anesthesiology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Alberto Uribe, M.D., Professor-Clinical, Ohio State University
    ClinicalTrials.gov Identifier:
    NCT03788980
    Other Study ID Numbers:
    • 2018H0044
    First Posted:
    Dec 28, 2018
    Last Update Posted:
    Oct 29, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Alberto Uribe, M.D., Professor-Clinical, Ohio State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 29, 2021